SCHEMBL6551601

SCHEMBL6551601

O=c1c(OCc2ccccc2)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(OCc3ccccc3)c12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLH Q9Y253 6/20 0.62
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 2/20 0.56
MMP1 P03956 2/20 0.56
POLB P06746 2/20 0.56
GAA P10253 2/20 0.56
MAPT P10636 2/20 0.56
APEX1 P27695 2/20 0.56
RECQL P46063 2/20 0.56
BLM P54132 2/20 0.56
KMT2A Q03164 2/20 0.56
HSD17B10 Q99714 2/20 0.56
HTT P42858 1/20 0.56
PPARG P37231 2/20 0.56
NOX4 Q9NPH5 3/20 0.55
SRC P12931 2/20 0.54
EPHX2 P34913 2/20 0.50
BCL9 O00512 1/20 0.50
ABCC4 O15439 1/20 0.50
MGAM O43451 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15228351 0.90 NOX4 (0.69) POLHKDM4EMEN1MMP1POLB
SCHEMBL3982524 0.90 PPARG (0.67) POLHKDM4EMEN1POLBMAPT
SCHEMBL8055794 0.87 POLH (0.53) POLHKDM4EMEN1MMP1POLB
SCHEMBL7940149 0.85 PPARG (0.62) MAPTPPARGABCB1ELANEADORA3
SCHEMBL15228364 0.83 POLH (0.54) POLHKDM4EMEN1MMP1POLB
SCHEMBL28516722 0.83 PPARG (0.53) POLHKDM4EMEN1POLBMAPT
SCHEMBL12691527 0.82 POLH (0.67) POLHKDM4EMEN1MMP1POLB
SCHEMBL118391 0.82 ADORA3 (0.61) POLHPOLBMAPTPPARGNOX4
SCHEMBL29410971 0.82 ADORA3 (0.61) POLHPOLBMAPTPPARGNOX4
SCHEMBL30424171 0.82 PPARG (0.69) MAPTPPARGBCHEABCB1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1463514-A2 UTILIZATION OF RUTINS AND AESCINS IN THE TREATMENT OF OCULAR CIRCULATORY DISTURBANCES Brench AG (DE) 2004-10-06 EP disclosed
EP-1385578-A1 UTILIZATION OF RUTINS AND AESCINS IN THE TREATMENT OF CIRCULATORY DISTURBANCES OF THE EAR Brench AG (DE) 2004-02-04 EP disclosed
WO-2002092063-A2 UTILIZATION OF RUTINS AND AESCINS IN THE TREATMENT OF OCULAR CIRCULATORY DISTURBANCES BRENCH AG (DE) 2002-11-21 WO disclosed
WO-2002089918-A1 UTILIZATION OF RUTINS AND AESCINS IN THE TREATMENT OF CIRCULATORY DISTURBANCES OF THE EAR BRENCH AG (DE) 2002-11-14 WO disclosed